Atopic Dermatitis

  • Nandita PatnaikEmail author
  • Francesca Darquea
Part of the Current Clinical Practice book series (CCP)


Atopic dermatitis is the most common chronic condition in children. It persists into adulthood in a significant percentage of individuals. The symptoms can be very troubling to families and impact quality of life. This condition often runs in families. The exact cause is unknown but in susceptible individuals is immunologically mediated. Relief of symptoms is done by keeping the skin moist through topical moisturizers, decreasing bacterial colonization through dilute bleach baths, and decreasing inflammation through the use of topical steroids and topical calcineurin inhibitors.


Atopic dermatitis Eczema Xerosis Filaggrin Moisturizers Dilute bleach baths Topical corticosteroids Topical calcineurin inhibitors 


  1. 1.
    Schneider L, Tilles S, Lio P, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295–9, e1–27. Scholar
  2. 2.
    Lyons JJ, Milner JD, Stone KD. Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am. 2015;35(1):161–83. Scholar
  3. 3.
    Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–51. Scholar
  4. 4.
    Jackson KD, Howie LD, Akinbami LJ. Trends in allergic conditions among children: United States, 1997–2011. NCHS Data Brief, No. 121. National Center for Health Statistics: Hyattsville; 2013.Google Scholar
  5. 5.
    Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s health. J Invest Dermatol. 2011;131(1):67–73. Scholar
  6. 6.
    Tollefson MM, Bruckner AL, Cohen BA, et al. Atopic dermatitis: skin-directed management. Pediatrics. 2014;134(6):e1735–44. Scholar
  7. 7.
    Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1980;92:44–7.Google Scholar
  8. 8.
    Williams HC, Jburney PG, Hay RJ, et al. The U.K. working Party's diagnostic criteria for atopic dermatitis. Br J Dermatol. 1994;131:383–96. Scholar
  9. 9.
    Eichenfield LF, Boguniewicz M, Simpson EL, et al. Translating atopic dermatitis management guidelines into practice for primary care providers. Pediatrics. 2015;136(3):554–65. Epub 2015 Aug 3.CrossRefGoogle Scholar
  10. 10.
    Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109–22. Epub 2015 Sep 13.PubMedCrossRefGoogle Scholar
  11. 11.
    Salmon JK, Armstrong CA, Ansel JC. The skin as an immune organ. West J Med. 1994;160:146–52.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Samuelov L, Sprecher E. Peeling off the genetics of atopic dermatitis-like congenital disorders. J Allergy Clin Immunol. 2014;134:808–15.PubMedCrossRefGoogle Scholar
  13. 13.
    Kezic S, Novak N, Jakasa I, et al. Skin barrier in atopic dermatitis. Front Biosci (Landmark Ed). 2014;19:542–56.CrossRefGoogle Scholar
  14. 14.
    FLG gene-Genetics Home Reference. (n.d.). Accessed on 13 Sept 2016.
  15. 15.
    Suárez-Fariñas M, Tintle S, Shemer A, et al. Non-lesional atopic dermatitis (AD) skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol. 2011 Apr;127(4):954–64.e1-4. Scholar
  16. 16.
    Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy. 2015;45(3):566–74. Scholar
  17. 17.
    Thomsen SF, Ulrik CS, Kyvik KO, et al. Importance of genetic factors in the etiology of atopic dermatitis: a twin study. Allergy Asthma Proc. 2007;28(5):535–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32. Scholar
  19. 19.
    Arkwright PD, Motala C, Subramanian H, Spergel J, Schneider LC, Wollenberg A. Management of difficult-to-treat atopic dermatitis. J Allergy Clin Immunol Pract. 2013;1:142–51. Scholar
  20. 20.
    Choi MJ, Maibach HI. Role of ceramides in barrier function of the healthy and diseased skin. Am J Clin Dermatol. 2005;6(4):215–23.PubMedCrossRefGoogle Scholar
  21. 21.
    Simpson E, Böhling A, Bielfeldt S, Bosc C, Kerrouche N. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatolog Treat . 2012 Sep 19 [Epub ahead of print]. Scholar
  22. 22.
    Simpson EL, Chalmers JR, Hanifin, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818–23. Scholar
  23. 23.
    Horimukai K, Morita K, Narita M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134:824–30,e6. Scholar
  24. 24.
    Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5(7):752–60.PubMedCrossRefGoogle Scholar
  25. 25.
    Darsow U, Pfab F, Valet M, Huss-Marp J, Behrendt H, Ring J, et al. Pruritus and atopic dermatitis. Clin Rev Allergy Immunol. 2011;41(3):237–44.PubMedCrossRefGoogle Scholar
  26. 26.
    Ohsawa Y, Hirasawa N. The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study. Allergol Int. 2014;63(4):533–42. Scholar
  27. 27.
    Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving the pruritis in atopic dermatitis. Arch Dematol. 1999;135(12):1522–5.CrossRefGoogle Scholar
  28. 28.
    Ong P, Leung D. The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am. 2010;30(3):309–21. Scholar
  29. 29.
    Huang JT, Abrams M, Tlougan B, Rademaker A, Paller S. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreased disease severity. Pediatrics. 2009;123(5):e808–14. Scholar
  30. 30.
    Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011;164(2):415–28. Epub 2010 Nov 23PubMedCrossRefGoogle Scholar
  31. 31.
    Lee JH, Son SW, Cho SH. A comprehensive review of the treatment of atopic eczema. Allergy Asthma Immunol Res. 2016;8(3):181–90. Scholar
  32. 32.
    Long CC, Finlay AY. The finger-tip unit—a new practical measure. Clin Exp Dermatol. 1991;16(6):444–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol. 1998;138(2):293–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Slattery MJ, Essex MJ, Paletz EM, et al. Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol. 2011;128(3):668–71.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Temple University School of MedicinePhiladelphiaUSA
  2. 2.Department of PediatricsCrozer-Chester Medical CenterChesterUSA

Personalised recommendations